185 related articles for article (PubMed ID: 34082608)
21. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
23. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
24. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
25. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
26. Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer.
Li C; Pang L; Jin F; Song Y; Zhou D; Song Y; Li Y; Jin S; Zhang L; Liang W; Shen X; Li J; She B; Wang C; Ma L
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436378
[TBL] [Abstract][Full Text] [Related]
27. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
28. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
30. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
31. SOX9 and IL1A as the Potential Gene Biomarkers of the Oral Cancer.
Li T; Cheng D; Guo J; Chen H; Zhang S; Bao Y
Comb Chem High Throughput Screen; 2023; 26(8):1461-1479. PubMed ID: 35762542
[TBL] [Abstract][Full Text] [Related]
32. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
33. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
Shen P; He X; Lan L; Hong Y; Lin M
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
[TBL] [Abstract][Full Text] [Related]
34. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
35. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
[TBL] [Abstract][Full Text] [Related]
36. Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer.
Liu RJ; Li SY; Liu LQ; Xu B; Chen M
Bioengineered; 2021 Dec; 12(1):2377-2388. PubMed ID: 34077304
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
[TBL] [Abstract][Full Text] [Related]
38. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
Yang Y; Jia B; Zhao X; Wang Y; Ye W
J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
[TBL] [Abstract][Full Text] [Related]
39. [Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].
Wang Y; Wang YS; Hu NB; Teng GS; Zhou Y; Bai J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):804-812. PubMed ID: 35680809
[TBL] [Abstract][Full Text] [Related]
40. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
